Most patients who present with lung metastases resulting from follicular cell–derived thyroid cancer (FCDTC) are found to have disease progression on long-term follow-up, according to investigators.
The findings, published in Thyroid (2016 Feb 12. [Epub ahead of print], PMID: 26872102), indicate a need for novel therapies to improve prognoses for these patients, the investigators wrote, noting that younger patients with low disease burden were an exception to their findings.
The